When was Ferryx founded?

Ferryx was founded in 2019 and raised its 1st funding round 3 years after it was founded.

Where is Ferryx located?

Ferryx is headquartered in Bristol, United Kingdom.

Who is the current CEO of Ferryx?

Jenny Bailey of Ferryx. They have also founded 1 company.

Which legal entities is Ferryx associated with?

Ferryx is associated with FERRYX LTD.

How many employees does Ferryx have?

As of May 31, 2026, the latest employee count at Ferryx is 5.

Is Ferryx a funded company?

Ferryx is a funded company, having raised a total of $827K across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 04, 2022.

How much is Ferryx worth?

The latest valuation of Ferryx is $***** as of Jul 31, 2023.

When was the latest funding round of Ferryx?

Ferryx's latest funding was a $***** Seed round on Jul 31, 2023, with participation from 0 investor.

Where does Ferryx rank among its competitors?

Ferryx ranks 9th amongst 128 active competitors, of which 16 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Myota, which secured $4.5M in Jun, 2026.

Who are the top competitors of Ferryx?

Ferryx's top competitors include Sova Health, Intralytix and Nemysis. Among them, Myota secured the most recent funding round in June, 2026.

Ferryx - 2026 Company Profile, Team, Funding, Competitors & Financials

Ferryx is a seed company based in Bristol (United Kingdom), founded in 2019 by Tristan Cogan and Jenny Bailey. It operates as a Developer of probiotics for gastrointestinal inflammatory diseases. Ferryx has raised $827K in funding, with a current valuation of $*****. The company has 128 active competitors, including 16 funded and 1 that has exited. Its top competitors include companies like Sova Health, Intralytix and Nemysis.

Company Details

Developer of probiotics for gastrointestinal inflammatory diseases. It offers live biotherapeutic products for human and veterinary use with lead product FX856, a live bacterial product which can be used for the prevention or treatment of gastrointestinal inflammation in humans or animals.

Website: ferryx.com
Social

Key Metrics

Founded Year

2019

Location

Bristol, United Kingdom

Stage

Seed

Total Funding

$827K in 3 rounds

Latest Funding Round

Seed, Jul 31, 2023, $*****

Post Money Valuation

$***** as on Jul 31, 2023

Investors

Deepbridge Capital & 1 more

Ranked

9^th among 128 active competitors

Employee Count

5 as on May 31, 2026

Similar Companies

Sova Health & 134 more

View Ferryx's full profile

Ferryx is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
FERRYX LTD CIN: 12193693 , United Kingdom, Active	Sep 05, 2019	-	2 (As on Sep 30, 2024)

Ferryx has raised a total funding of $827K over 3 rounds. Its first funding round was on Apr 04, 2022. Ferryx has 1 institutional investor and 1 angel investor.

Here is the list of recent funding rounds of Ferryx:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 31, 2023	6800122	Seed	4912422	5174028	8230031	6884540
Sep 15, 2022	9727533	Seed	7630033	6522668	7642282	Deepbridge Capital
Apr 04, 2022	1958547	Seed	2222919	1126774	3486262	7982964

Access funding benchmarks and valuations. Sign up today!

View details of Ferryx's funding rounds and investors

The founders of Ferryx are Tristan Cogan and Jenny Bailey. Jenny Bailey is the CEO of Ferryx.

Here are the details of Ferryx's key team members:

Tristan Cogan: Co-Founder of Ferryx. They serve on the board of 1 company.
Contact Info: 1 email address
Jenny Bailey: Co-Founder & CEO of Ferryx.
Contact Info: 1 email address

Ferryx's Board of Directors

Ferryx's board has 7 active members. Tristan Cogan, Jennifer Ruth Bailey, Tristan Alexander Cogan and John Stephen Fox are part of team and Le Roy Dowey, Jennifer Bailey and John Fox are independent board members.

Here is the list of Ferryx's board of directors:

Name	Type	Representing	Status	Duration
Tristan Cogan	Team	-	Current	6y 8m
Jennifer Ruth Bailey	Team	-	Current	6y 8m
Tristan Alexander Cogan	Team	-	Current	6y 8m
John Stephen Fox	Team	-	Current	6y 8m
Le Roy Dowey	Independent board member	-	Current	4y 2m
sdwcwib	Independent board member	-	Current	2y 9m
pyfvwac	Independent board member	-	Current	7y 7m
gi{geqb	Independent board member	-	Past	8y 8m

View details of Ferryx's Founder profiles and Board Members

Ferryx's employee count trend

Ferryx has 5 employees as of May 26. Here is Ferryx's employee count trend over the years:

Uncover Ferryx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Ferryx include Sova Health, Intralytix and Nemysis. Here is the list of Top 10 competitors of Ferryx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sova Health 2019, Gurugram (India), Seed	Provider of a gut-health and personalised wellness supplements	$1.35M	Antler, LetsVenture & 12 others	55/100
2nd	Intralytix 1999, Baltimore (United States), Series A	Bacteriophage technology company focused on controlling bacterial pathogens in various settings	$17.5M	National Science Foundation, United States Department of Agriculture ... & 1 others	54/100
3rd	Nemysis 2015, Dublin (Ireland), Series A	Solutions for iron deficiency/anemia and gluten intolerance	$4.1M	Aviapharma, KOLINPHARMA & 1 others	51/100
4th	Myota 2022, London (United Kingdom), Series A	Developer of prebiotic supplements for gut health	$4.5M	PeakBridge	39/100
5th	ISOVive 2013, Manassas (United States), Series A	Provider of prebiotic supplement for digestive support and gut health	$8.14M	-	38/100
6th	LifeChart Ayurveda 2022, Gurugram (India), Seed	Gut health-tech company developing ayurvedic healthcare solutions	$1.52M	Prajay Advisors, Sunn91 & 41 others	38/100
7th	Goodbug.in 2026, India, Unfunded	Provider of probiotic supplements to support gut health and overall wellness	-	-	37/100
8th	rmdy 2018, Philadelphia (United States), Funding Raised	Developer of chewable tablets for improving digestion	-	Dorm Room Fund, Brand Foundry & 2 others	35/100
9th	Ferryx 2019, Bristol (United Kingdom), Seed	Developer of probiotics for gastrointestinal inflammatory diseases	$827K	Deepbridge Capital & 1 others	33/100
10th	Good Bacteria Portland (United States), Seed	Provider of rotating probiotic system designed to support gut microbiome health	$3.2M	BrandProject, Listen VC & 2 others	31/100